已核实 DOI PubMed 相关产品: 0

Cu2O/WO3 S-scheme heterojunctions for photocatalytic degradation of levofloxacin based on coordination activation

Journal 2024 · IF 8.1 · 发表于 2024 年 2 月 12 日
作者: Qi Chen,Ling Hu,Yingzhang Shi,Cheng Liu,Yidong Hou,Jinhong Bi,Jimmy C. Yu,Ling Wu
阅读全文 在 PubMed 查看

摘要

Heterogeneous photocatalytic degradation of antibiotic involves the activation of antibiotic molecules and the photocatalytic oxidation process. However, the simultaneous improvement of these processes is still a challenge. Herein, S-scheme heterojunctions consisted of Cu 2 O nanocluster with defective WO 3 nanosheets were constructed for efficient photocatalytic degradation of levofloxacin (LVX). The typical CNS-5 composite (5 wt% Cu 2 O/WO 3 ) achieves an optimal LVX degradation efficiency of 97.9% within 80 min. The spatial charge separation and enhancement of redox capacity were realized by the formation of S-scheme heterojunction between Cu 2 O and WO 3 . Moreover, their interfacial interaction would lead to the loss of lattice oxygen and the generation of W 5+ sites. It is witnessed that the C–N of piperazine ring and C O of carboxylic acid in LVX are coordinated with W 5+ sites to build the electronic bridge to activate LVX, greatly promoting the further degradation. This work highlights the important role of selective coordination activation cooperated with S-type heterojunctions for the photocatalytic degradation and offers a new view to understand the degradation of antibiotics at molecular level.